|
1
|
Siegel R, Desantis C and Jemal A:
Colorectal cancer statistics, 2014. CA Cancer J Clin. 64:104–117.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel R, Ma J, Zou Z and Jemal A: Cancer
statistics, 2014. CA Cancer J Clin. 64:9–29. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Eilstein D, Hedelin G and Schaffer P:
Incidence of colorectal cancer in Bas-Rhin, trend and prediction in
2009. Bull Cancer. 87:595–599. 2000.In French. PubMed/NCBI
|
|
4
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2012. CA Cancer J Clin. 62:10–29. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Adam R, Haller DG, Poston G, et al: Toward
optimized front-line therapeutic strategies in patients with
metastatic colorectal cancer-an expert review from the
International Congress on Anti-Cancer Treatment (ICACT) 2009.
Annals of Oncology. 21:1579–1584. 2010. View Article : Google Scholar
|
|
6
|
Hatakeyama S, Watanabe M, Fujii Y and
Nakayama KI: Targeted destruction of c-Myc by an engineered
ubiquitin ligase suppresses cell transformation and tumor
formation. Cancer Res. 65:7874–7879. 2005.PubMed/NCBI
|
|
7
|
Suzuki Y, Demoliere C, Kitamura D,
Takeshita H, Deuschle U and Watanabe T: HAX-1, a novel
intracellular protein, localized on mitochondria, directly
associates with HS1, a substrate of Src family tyrosine kinases. J
Immunol. 158:2736–2744. 1997.PubMed/NCBI
|
|
8
|
Chao JR, Parganas E, Boyd K, Hong CY,
Opferman JT and Ihle JN: Hax1-mediated processing of HtrA2 by Parl
allows survival of lymphocytes and neurons. Nature. 452:98–102.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wyllie AH, Kerr JF, Macaskill IA and
Currie AR: Adrenocortical cell deletion: the role of ACTH. J
Pathol. 111:85–94. 1973. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Radhika V, Onesime D, Ha JH and
Dhanasekaran N: Galpha13 stimulates cell migration through
cortactin-interacting protein Hax-1. J Biol Chem. 279:49406–49413.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yedavalli VS, Shih HM, Chiang YP, et al:
Human immunodeficiency virus type 1 Vpr interacts with
antiapoptotic mitochondrial protein HAX-1. J Virol. 79:13735–13746.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Vafiadaki E, Sanoudou D, Arvanitis DA,
Catino DH, Kranias EG and Kontrogianni-Konstantopoulos A:
Phospholamban interacts with HAX-1, a mitochondrial protein with
anti-apoptotic function. J Mol Biol. 367:65–79. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Vafiadaki E, Arvanitis DA, Pagakis SN, et
al: The anti-apoptotic protein HAX-1 interacts with SERCA2 and
regulates its protein levels to promote cell survival. Mol Biol
Cell. 20:306–318. 2009. View Article : Google Scholar :
|
|
14
|
Sun SJ, Feng L, Zhao GQ and Dong ZM: HAX-1
promotes the chemoresistance, invasion, and tumorigenicity of
esophageal squamous carcinoma cells. Dig Dis Sci. 57:1838–1846.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Banerjee A, Saito K, Meyer K, et al:
Hepatitis C virus core protein and cellular protein HAX-1 promote
5-fluorouracil-mediated hepatocyte growth inhibition. J Virol.
83:9663–9671. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Luo X, Li Z, Li X, et al: hSav1 interacts
with HAX1 and attenuates its anti-apoptotic effects in MCF-7 breast
cancer cells. Int J Mol Med. 28:349–355. 2011.PubMed/NCBI
|
|
17
|
Li X, Luo X, Li Z, et al: Screening of
binding proteins that interact with human Salvador 1 in a human
fetal liver cDNA library by the yeast two-hybrid system. Mol Biol
Rep. 39:8225–8230. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Jiang J, Liu L, Li X, Tao D, Hu J and Qin
J: Defining the restriction point in normal asynchronous human
peripheral blood lymphocytes. Cytometry A. 83:944–951.
2013.PubMed/NCBI
|
|
19
|
Lees DM, Hart IR and Marshall JF:
Existence of multiple isoforms of HS1-associated protein X-1 in
murine and human tissues. J Mol Biol. 379:645–655. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Carlsson G, van't Hooft I, Melin M, et al:
Central nervous system involvement in severe congenital
neutropenia: neurological and neuropsychological abnormalities
associated with specific HAX1 mutations. J Intern Med. 264:388–400.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Han Y, Chen YS, Liu Z, et al:
Overexpression of HAX-1 protects cardiac myocytes from apoptosis
through caspase-9 inhibition. Circ Res. 99:415–423. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Fadeel B and Grzybowska E: HAX-1: a
multifunctional protein with emerging roles in human disease.
Biochim Biophys Acta. 1790:1139–1148. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Rhodes DR, Yu J, Shanker K, et al:
ONCOMINE: a cancer microarray database and integrated data-mining
platform. Neoplasia. 6:1–6. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Trebinska A, Rembiszewska A, Ciosek K, et
al: HAX-1 overexpression, splicing and cellular localization in
tumors. BMC Cancer. 10:762010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wei XJ, Li SY, Yu B, Chen G, Du JF and Cai
HY: Expression of HAX-1 in human colorectal cancer and its clinical
significance. Tumour Biol. 35:1411–1415. 2014. View Article : Google Scholar
|
|
26
|
Ashhab Y, Alian A, Polliack A, Panet A and
Ben Yehuda D: Two splicing variants of a new inhibitor of apoptosis
gene with different biological properties and tissue distribution
pattern. FEBS Lett. 495:56–60. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Li M, Tang Y, Zang W, et al: Analysis of
HAX-1 gene expression in esophageal squamous cell carcinoma. Diagn
Pathol. 8:472013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kaufmann SH and Gores GJ: Apoptosis in
cancer: cause and cure. Bioessays. 22:1007–1017. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Schmitt CA: Senescence, apoptosis and
therapy - cutting the lifelines of cancer. Nat Rev Cancer.
3:286–295. 2003. View
Article : Google Scholar : PubMed/NCBI
|
|
30
|
Nachmias B, Ashhab Y, Bucholtz V, et al:
Caspase-mediated cleavage converts Livin from an antiapoptotic to a
proapoptotic factor: implications for drug-resistant melanoma.
Cancer Res. 63:6340–6349. 2003.PubMed/NCBI
|
|
31
|
Deng W, Wang DA, Gosmanova E, Johnson LR
and Tigyi G: LPA protects intestinal epithelial cells from
apoptosis by inhibiting the mitochondrial pathway. Am J Physiol
Gastrointest Liver Physiol. 284:G821–G829. 2003. View Article : Google Scholar : PubMed/NCBI
|
